SCHEMBL13686293

SCHEMBL13686293

CCOC(C)n1nc(Br)c2cc(C3OC(C)O3)sc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3819537 0.73 KDM4E (0.38) —
SCHEMBL18529056 0.71 PKM (0.43) —
SCHEMBL29511790 0.54 HSD17B10 (0.33) —
SCHEMBL18529006 0.54 HSD17B10 (0.33) —
SCHEMBL13349383 0.51 — —
SCHEMBL29164347 0.51 JAK2 (0.31) —
SCHEMBL13226766 0.51 ALDH1A1 (0.42) —
SCHEMBL2556110 0.49 L3MBTL1 (0.36) —
SCHEMBL1300155 0.48 JAK2 (0.41) —
SCHEMBL12948529 0.45 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595320-B2 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof AVENTIS PHARMA S.A. (FR) 2009-09-29 — — US disclosed
US-20080146542-A1 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, Process for Preparing Them, Compositions Containing Them and Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-19 — — US disclosed
Send feedback